Which hedge funds own DSGN? DESIGN THERAPEUTICS INC, Q2 2026 13F holders
HealthcareBiotechnologyFollow
31 tracked hedge funds disclosed a position in DSGN (DESIGN THERAPEUTICS INC) in their Q2 2026 13F filings, worth $261.2m in total. The largest holder by portfolio weight is Trails Edge Capital Partners, LP at 4.6% of its book. 12 opened a new position this quarter: KVP Capital Advisors, LP, Sofinnova Investments, Inc., Frazier Life Sciences Management, L.P., DAFNA Capital Management LLC. 8 exited: Kynam Capital Management, LP, RA Capital Management, L.P., Lynx1 Capital Management LP.
31
Holders
Tracked managers whose filing for the quarter reports a long equity position in the security.
12
New this quarter
Holders whose previous filing (at most two quarters earlier) did not report the security.
8
Exited this quarter
Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
$51.9m
Inflow, new holders
Combined value of the positions the new holders reported for the quarter.
$43.4m
Outflow, exits
Combined value the exiting managers reported for the security in their previous filing.
$261m
Combined value
Sum of the holders' reported positions in the security.
2.5%
Share of managers holding
Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.